BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25673032)

  • 1. Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size.
    Nomori H; Cong Y; Sugimura H; Kato Y
    Surg Today; 2015 Dec; 45(12):1535-41. PubMed ID: 25673032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
    Mori T; Nomori H; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Oncol; 2008 Apr; 3(4):358-64. PubMed ID: 18379353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of diffusion weighted imaging of malignant and benign pulmonary nodules and masses: comparison with positron emission tomography.
    Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Maeda S; Matoba M; Kuginuki Y; Taniguchi M; Tonami H; Ueda Y; Sakuma T
    Asian Pac J Cancer Prev; 2014; 15(11):4629-35. PubMed ID: 24969896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
    Nomori H; Cong Y; Abe M; Sugimura H; Kato Y
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):991-6. PubMed ID: 25686657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer?
    Ohba Y; Nomori H; Mori T; Ikeda K; Shibata H; Kobayashi H; Shiraishi S; Katahira K
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):439-45. PubMed ID: 19619793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
    Ann Thorac Surg; 2005 Mar; 79(3):984-8; discussion 989. PubMed ID: 15734419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla.
    Ohba Y; Nomori H; Mori T; Shiraishi K; Namimoto T; Katahira K
    Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):108-14. PubMed ID: 21471253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of semiquantitative assessments of fluorodeoxyglucose uptake on positron emission tomography scans for the diagnosis of pulmonary malignancies 1 to 3 cm in size.
    Ohba Y; Nomori H; Shibata H; Kobayashi H; Mori T; Shiraishi S; Nakashima R
    Ann Thorac Surg; 2009 Mar; 87(3):886-91. PubMed ID: 19231413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of diffusion-weighted imaging versus 18F-FDG PET/CT in differentiating pulmonary lesions: an updated meta-analysis of comparative studies.
    Liu J; Xia X; Zou Q; Xie X; Lei Y; Wan Q; Li X
    BMC Med Imaging; 2023 Mar; 23(1):37. PubMed ID: 36899303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer.
    Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Kuginuki Y; Taniguchi M; Ueda Y; Sakuma T
    Ann Surg Oncol; 2013 May; 20(5):1676-83. PubMed ID: 23242821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
    Farid K; Poullias X; Alifano M; Regnard JF; Servois V; Caillat-Vigneron N; Petras S
    Nucl Med Commun; 2015 Jul; 36(7):722-7. PubMed ID: 25793929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging and positron emission tomography in various cytological subtypes of primary lung adenocarcinoma.
    Tanaka R; Nakazato Y; Horikoshi H; Tsuchida S; Yoshida T; Nakazato Y; Tachibana K; Kondo H; Goya T
    Clin Imaging; 2013; 37(5):876-83. PubMed ID: 23849098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.